Medication info
MicarTel 80 mg Tablets (Telmisartan)

MicarTel 80 mg Tablets (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
White or whitish oval tablet
Packaging
30 tablets (10 tablets/PTP packaging x 3)
Approval status
Active

MFDS item code 201502263 · Approved 2015.04.15 · Insurance code 644102650

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine provides an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases in high-risk patients

  • Essential hypertension
View approved original text

This medication helps control blood pressure in patients with essential hypertension. It is also used to lower the risk of myocardial infarction, stroke, and mortality from cardiovascular diseases in patients aged 55 and older, with a history of major cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and stroke, or who are at high cardiovascular risk. It is especially suitable for individuals who find it difficult to take ACE inhibitors. Thus, this medication effectively reduces the risk of cardiovascular diseases and improves health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine provides an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn during pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Women who are pregnant, may become pregnant, or are nursing should not take this medication. Patients with severely impaired liver function, biliary obstruction, or cholestasis should avoid taking this medication. Patients with hypersensitivity or hereditary angioedema should also refrain from using it. Diabetic patients or those with moderate to severe renal impairment should avoid combination with certain medications. Elderly patients, those with hyperkalemia, and patients with slightly impaired liver function should take this medication with caution. Patients with heart or vascular issues, or gastrointestinal diseases should also take it cautiously. This medication lowers blood pressure which may result in symptoms of hypotension, dizziness, or fainting. Various adverse reactions may occur including hyperkalemia, worsening renal function, liver function abnormality, angioedema; therefore, immediate consultation with a healthcare provider is necessary if symptoms occur. Specifically, if blood pressure drops too low or severe muscle pain, difficulty breathing, or rash occurs, the medication should be discontinued immediately and medical treatment secured. This medication may interact with other antihypertensive medications, so consult with a doctor. Caution is also required when co-administering with lithium, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs). It is best to avoid taking this medication within 24 hours prior to surgery. Safety and efficacy in children and individuals under 18 are not established and thus not recommended. Elderly patients are at risk of stroke due to excessive blood pressure reduction, so their condition should be closely monitored during use. In case of overdose, hypotension, dizziness, acute renal failure may occur requiring immediate medical treatment. This medication should be kept out of reach of children and stored away from moisture. Women who are pregnant or nursing should consult with a healthcare provider before taking this medication and discontinue immediately if pregnancy is confirmed while on it. During treatment, regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary for any abnormalities. Exercise caution when driving or operating dangerous machinery due to potential dizziness or fainting.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 103 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • malaise
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • hepatic dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • chest X-ray abnormalities
  • rhabdomyolysis
  • myalgia
  • increased creatine kinase
  • increased serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • cough
  • dyspepsia
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture, and keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication.

Appearance and packaging

Appearance

White or whitish oval tablet

Package unit

30 tablets (10 tablets/PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.